top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Cancer Nanomedicine
Cancer Nanomedicine
Autore Hoskins Clare
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (510 p.)
Soggetto topico Technology: general issues
Soggetto non controllato antibody drug conjugate (ADC)
PD-L1
tumor spheroid disruption
immune modulation
doxorubicin
graphene oxide
adsorption
cathepsin D
cathepsin L
anti-metastatic enzyme cancer therapy
nanoparticles
targeted delivery system
siRNA
osteopontin
mammary carcinoma
mesenchymal stem cells (MSCs)
TAT peptide
PLGA
paclitaxel
nano-engineered MSCs
orthotopic lung tumor model
intracranial glioma
immunotherapy
CPMV
viral nanoparticles
in situ vaccine
albumin nanoparticles
microbubble
ultrasound
theranostics
hepatocellular carcinoma
VX2 tumor
intra-arterial chemotherapy
lung cancer
nanomedicine
clinical status
cancer therapy
breast cancer
cell signaling
active targeting
passive targeting
EPR effect
oncogenes
nanoparticle
drug delivery
ligand
tumor targeting
biodistribution
Mesoporous silica nanoparticle
drug delivery system
target treatment
lanthanide metal
hyaluronic acid
hyaluronidase
drug combination
everolimus
dual-targeting
magnetic nanoparticles
monoclonal antibodies
nanostructured lipid carrier
platelet membrane
biomimicry
plasmonic photothermal therapy
gold nanorods
surgery
bleeding
dogs
cats
stimuli-responsive
DOX
SN38
CSCs
single-walled carbon nanotubes
chirality separation
NASH
drug-gene delivery
near IR hyperspectral imaging
plasmonics
copper
VEGF
glioblastoma
differentiated neuroblastoma
peptidomimetics
real-time quantitative polymerase chain reaction (qPCR)
actin
combinatorial therapy
anticancer and antibacterial activity
temoporfin
drug-in-cyclodextrin-in-liposome
hybrid nanoparticles
multicellular tumor spheroids
cyclodextrins
photodynamic therapy article
yet reasonably common within the subject discipline
antitumor strategy
biomimetic core–shell nanoparticles
NK cell-derived exosomes
folate receptor
albumin nanoparticle
microfluidic
cabazitaxel
polydopamine nanoparticles
size
cytotoxicity
iron affinity
FA-DABA-SMA
self-assembly
oncogenic proteins
intracellular disruption
folic receptor alpha
pancreatic cancer
parvifloron D
albumin
erlotinib
photodynamic therapy
lipid nanoparticles
tumor vectorization
verteporfin
ovarian carcinomatosis
spheroids
integrin
RGD peptide
cancer diagnosis
radiotherapy
hyperthermia therapy
biomimetic
nanocarrier
membrane-wrapped
cancer
targeted delivery
photothermal therapy
imaging
cancer nanomedicine
tumor microenvironment
nano–bio interactions
clinical translation
magnetic nanowires
magnetic hyperthermia
magnetic actuation
magnetic drug targeting
titanate nanotubes
gold nanoparticles
vectorization
colloidal stability
docetaxel
prostate cancer
mangiferin
anti-topoisomerase activity
extracellular vesicles
exosomes
chemico-physical functionalization
loading
translational medicine
nanotechnology: bioengineering
anacardic acid
mitoxantrone
targeted drug delivery
liposomes
melanoma
apoptosis
ascorbic acid
angiogenesis
epithelial-to-mesenchymal transition
hypoxia
immunosuppression
metabolism
nanotherapeutics
tumour microenvironment
DNA origami
liposome
remote loading
acute toxicity
organoids
magnetic silica-coated iron oxide nanochains
photothermal treatment
hyperthermia
collagen
cellular microenvironment
lymphadenectomy
magnetometer
sentinel lymph node dissection
SPION
superparamagnetic iron oxide nanoparticles
Vδ2 T cells
zoledronic acid
polymeric nanoconstruct
anti-tumor immunity
colorectal carcinoma
β-cyclodextrin nanosponges
BALB-neuT mice
brain tumours
glioma
blood brain barrier
polymeric nanoparticles
PEGylation
dioleoylphosphatidylethanolamine
poly(hydroxyethyl acrylate-co-allyl methyl sulfide) copolymer
folate
oxidation-sensitive release
cellular interaction
in vitro anti-cancer activity
triple negative breast cancer
organotin
mesoporous silica nanoparticles
MDA-MB-231
theranostic nanomaterials
nanobiotechnology
molecular imaging
nanosystems
nanomicelles
ovarian cancer
tumour targeting
chemotherapeutics
riboflavin
vitamin B2
nanomedicines
secondary structure
mixed micelle
pH responsive
targeted therapy
anti-cancer
shear stress
flow
in vitro
therapeutics
diagnostics
Immunotherapy
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557114703321
Hoskins Clare  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches
Lysosomal Storage Disorders: Molecular Basis and Therapeutic Approaches
Autore Moro Enrico
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (301 p.)
Soggetto topico Medicine
Soggetto non controllato mucopolysaccharidosis IIIB
quantitative proteomics
NAGLU
lysosomes
Gaucher disease
bone involvement
enzyme replacement therapy
substrate reduction therapy
Osteoimmunology
RANK/RANKL
Osteopontin
MIP-1β
mucolipidosis II
sortilin
TGF-beta
cathepsin D
Fabry disease
alpha-galactosidase A
endocytosis
lysosome
IGF2R/M6P
clathrin
chloroquine
lysosomal diseases
precision medicine
pharmacological chaperones
gene therapy
Pompe disease
lysosomal targeting
autophagy
muscle
satellite cells
rhGAA
glycogen
lysosomal α-glucosidase
GAA biomarker
Gaucher Disease
Wnt/β-catenin
Dkk1
Wnt3a
iPSC
neuronopathy
Krabbe disease
Twitcher mouse
psychosine
visual system
visual cortex
astrogliosis
mucopolysaccharidosis type I
Hurler syndrome
hematopoietic stem cell transplantations
animal models
experimental therapies
axon guidance
lysosomal storage disorders
neuronal circuit
α-galactosidase A
A4GALT
globotriaosylceramide (Gb3)
globotriaosyl-sphingosine (lysoGb3)
pharmacological chaperone therapy
exosomes
endocytic pathways
neurodegenerative disease
Parkinson disease
lysosomal storage disorder
viral vectors
newborn screening
variant interpretation
second tier test
tandem mass spectrometry
lyso-Gb3
dried blood spot
GLA gene
globotriaosylsphingosine
biomarkers
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Lysosomal Storage Disorders
Record Nr. UNINA-9910557545503321
Moro Enrico  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Novel Processing Technology of Dairy Products
Novel Processing Technology of Dairy Products
Autore Moschopoulou Ekaterini
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (118 p.)
Soggetto topico Technology: general issues
Chemical engineering
Soggetto non controllato recrystallization
food hydrocolloids
methods for crystal structure evaluation
high hydrostatic pressure
whey protein hydrolysates
sheep milk
yoghurt
ACE inhibitory activity
gel properties
heat stability
traditional yoghurt starter
biofunctionality
alpha-lactalbumin (α-Lac)
beta-lactoglobulin (β-Lg)
high pressure processing (HPP)
pasteurization
ready-to-feed (RTF) infant formula
milk phospholipids
buttermilk
life-cycle assessment
carbon footprint
supercritical fluid extraction
membrane separation
microfiltration
ovine milk
bovine milk
casein fractions
alkaline phosphatase
cathepsin D
milk renneting properties
probiotics
viability model
high-pressure processing
rheology
sensory quality
fermented dairy beverage
antioxidant capacity
microbial inactivation
image analysis
high pressure processing
total phenolic content
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910580211503321
Moschopoulou Ekaterini  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Proteases—From Basic Structure to Function to Drug Design as Targeted Therapy
Proteases—From Basic Structure to Function to Drug Design as Targeted Therapy
Autore Kwok Hang Fai
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (93 p.)
Soggetto topico Research & information: general
Soggetto non controllato MMP
MMP2
MMP9
MMP7
MMP14
matrix metalloproteases
PDAC
pancreatic cancer
Bowman–Birk inhibitor
ranacyclin
trypsin inhibitor
structure–activity relationship
synergistic effect
Gentamicin
matrix metalloproteinase
extracellular matrix
nuclei
cancer
apoptosis
immune response
cysteine protease inhibitor
stefin
signal peptide
parasite
phylogenetic analysis
diversification
protein structure
vascular endothelial growth factors (VEGFs)
VEGF-A
PlGF
VEGF-B
VEGF-C
VEGF-D
angiogenesis
lymphangiogenesis
CCBE1
proteases
ADAMTS3
plasmin
cathepsin D
KLK3
prostate-specific antigen (PSA)
thrombin
wound healing
metastasis
proteolytic activation
vascular biology
lymphedema
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557353103321
Kwok Hang Fai  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui